Loading organizations...
Saras Capital is a private investment firm providing strategic capital solutions within the venture capital landscape. Based in the UK, it focuses on enabling growth for companies, particularly in the biotech and healthcare sectors. The firm delivers financial backing and expertise, emphasizing regulated partnerships and global insights to support its portfolio.
Established in 2020, Saras Capital was co-founded by Nadav Rosenberg, who also serves as an investor. The firm originated from the insight that promising company founders, especially in specialized fields, greatly benefit from strategic investment partners. Its inception aimed to provide supportive, engaged minority shareholding to foster innovation.
Saras Capital primarily serves early-stage companies and their founders, alongside limited partners in its funds. The firm’s overarching vision is to be a premier minority shareholder, actively supporting its portfolio businesses. It dedicates itself to empowering founders, particularly within the biotech and healthcare industries, to realize their long-term potential.
Saras Capital has 5 tracked investments across 5 companies. The latest tracked deal is $2.8M Seed in Cellbyte in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 18, 2025 | Cellbyte | $2.8M Seed | William Mcquillan | Pace Ventures, Springboard Health Angels, TOM Blomfield |
| Nov 12, 2025 | Modulight Biotherapeutics | $12.2M Seed | Jibe Ventures, LocalGlobe | Fresh Fund, John Propst, Phd, MBA, Redseed, Secret Chord Ventures, Sha'ar Mivnim, Silver ARC Private Capital |
| May 1, 2025 | Kyron.bio | $6.0M Seed | — | Hardware Club, Singular, Speedinvest, Verve Ventures, Entrepreneur First |
| Dec 14, 2023 | Parse Biosciences | $50.0M Series C | David Canner | Bioeconomy Capital, Janus Henderson Investors, Marshall Wace, Sahsen Ventures |
| Nov 1, 2022 | Eden Bio | $1.0M Seed | Synbioven | 7percent Ventures, Dragonfly Capital, Hack VC, Meta Change Capital, #secretfund, Unruly Capital, Spencer Noon, XAnge, Didier Valet, Ernest Oppetit, Fernando Martinelli, Frederic Montagnon, Itamar Lesuisse, John Lilic, Julien Romanetto, Nicolas Debock, Nicolas Steegmann, Andy Russell, Kevin Mascarenhas, Noor Shaker, Stefano Bernardi, Dhyan Capital |